GSK and XenoPort receive FDA approval for Horizant® for postherpetic neuralgia
7 June 2012 | By GlaxoSmithKline
The US FDA has approved Horizant® (gabapentin enacarbil)...
List view / Grid view
7 June 2012 | By GlaxoSmithKline
The US FDA has approved Horizant® (gabapentin enacarbil)...
9 August 2011 | By GlaxoSmithKline
GSK and XenoPort, Inc. request approval of Horizant™...